FDA guidance updates postmarket surveillance program

08/18/2011 | MassDevice.com (Boston)

The FDA has issued guidance outlining the types of devices that may be eligible for postmarket surveillance as well as how manufacturers should comply with the program. The guidance, which will be up for comment over the next three months, also recommends that the 36-month surveillance period be extended for pediatric devices.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC